embB Resolved · high auto-curated

H37Rv Rv3795 · MTBC0 mtbc0_004023 · 1098 aa · 4270635–4273931 MTBC0 (+) · RefSeq NP_218312.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)arabinosyltransferase B
MTBC0 PGAP re-annotationarabinosyltransferase EmbB
Revised (this work)Arabinosyltransferase EmbB. Pfam: Arabino_trans_N (PF17689.9), Arabinose_trans (PF04602.19), Arabino_trans_C (PF14896.13).
Functional category (TubercuList)cell wall and cell processes

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 317 publications

317 TB publications mention this gene. 317 publications discuss this gene. Queried separately, 306 records carry a M. tuberculosis context and 24 a non-TB mycobacterial context (species named in the 24-record verified sample: M. smegmatis (20), M. abscessus (3), M. leprae (3)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 317: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Analysis of Drug Resistance Characteristics and Risk Factors of Cavitary Tuberculosis Based on Whole Genome Sequencing and Machine Learning. doi:10.1093/ofid/ofag328 2026
Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis. doi:10.3390/pathogens15050455 2026
Global Status of Ethambutol Resistance in Mycobacterium tuberculosis Clinical Isolates: An Updated Systematic Review and Meta-Analysis. doi:10.1177/10766294261448630 2026
Utilization of a CRISPRi-based ex vivo challenge model to reveal temporally dependent gene essentiality in intracellular Mycobacterium tuberculosis. doi:10.1128/mbio.00610-26 2026
First-line drug-resistant tuberculosis among children under 15 years in Ethiopia: insights from phenotypic and whole-genome sequencing approaches. doi:10.1186/s12879-026-13206-9 2026
327 records returned by the alias sweep (a separate sweep from the 317 above; both are shown, neither is exhaustive)

Searched as: Rv3795, embB, Mb3824, ML0104c, MMAR_5357, MSMEG_6389, MAB_0185c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Comparative whole genome analysis of Mycobacterium tuberculosis isolated from BPaLM and individualized regimen treated patients at Dr. Soetomo Hospital, Indonesia. doi:10.1007/s11033-026-12652-7 Mol Biol Rep 2026
Encoded metabolic remodeling amplifies drug resistance in Mycobacterium tuberculosis. doi:10.1371/journal.ppat.1014237 PLoS Pathog 2026
Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction in Mycobacterium tuberculosis clinical isolates. doi:10.3389/fmicb.2026.1828991 Front Microbiol 2026
Analysis of Drug Resistance Characteristics and Risk Factors of Cavitary Tuberculosis Based on Whole Genome Sequencing and Machine Learning. doi:10.1093/ofid/ofag328 Open Forum Infect Dis 2026
Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis. doi:10.3390/pathogens15050455 Pathogens 2026
Global Status of Ethambutol Resistance in Mycobacterium tuberculosis Clinical Isolates: An Updated Systematic Review and Meta-Analysis. doi:10.1177/10766294261448630 Microb Drug Resist 2026
Utilization of a CRISPRi-based ex vivo challenge model to reveal temporally dependent gene essentiality in intracellular Mycobacterium tuberculosis. doi:10.1128/mbio.00610-26 mBio 2026
First-line drug-resistant tuberculosis among children under 15 years in Ethiopia: insights from phenotypic and whole-genome sequencing approaches. doi:10.1186/s12879-026-13206-9 BMC Infect Dis 2026
Investigation of Gene Regions Responsible for Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis Complex Resistant to at Least Two First-Line Anti-Tuberculosis Drugs. doi:10.3390/pathogens15020222 Pathogens 2026
In Silico Design of gRNA for CRISPR System for Detection of Multidrug Resistant Tuberculosis Using Indian Mycobacterium tuberculosis Genomes: A Computational Study. doi:10.7759/cureus.101851 Cureus 2026
First insight of characteristics and prediction of Mycobacterium tuberculosis drug resistance by whole genome sequencing in Fujian Province, China. doi:10.1038/s41598-026-40398-6 Sci Rep 2026
Isolation, identification and genomic analysis of Mycobacterium caprae strain SY-1 from Chinese sika deer (Cervus nippon). doi:10.1186/s12864-026-12540-1 BMC Genomics 2026
Genomic landscape of Mycobacterium tuberculosis: Identifying mutation hotspots and stable regions for implications for drug development. doi:10.1016/j.nmni.2025.101674 New Microbes New Infect 2025
Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015). doi:10.1186/s12879-025-11913-3 BMC Infect Dis 2025
Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis. doi:10.3389/fcimb.2025.1641385 Front Cell Infect Microbiol 2025
Disulfide bonds are critical for stabilizing cell division, cell envelope biogenesis, and antibiotic resistance proteins in mycobacteria. doi:10.1128/mbio.01083-25 mBio 2025
Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China. doi:10.1186/s12879-025-11356-w BMC Infect Dis 2025
Lineage identification and mutation profile of Mycobacterium tuberculosis: A study from National Reference Laboratory, India. doi:10.1016/j.ijmmb.2025.100925 Indian J Med Microbiol 2025
Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development. doi:10.1186/s12879-025-11227-4 BMC Infect Dis 2025
Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China. doi:10.3389/fcimb.2025.1586938 Front Cell Infect Microbiol 2025
An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens. doi:10.1186/s12890-025-03747-1 BMC Pulm Med 2025
Genomic characterization of multidrug-resistant tuberculosis in Shanghai, China: antibiotic resistance, virulence and transmission. doi:10.1093/jacamr/dlaf064 JAC Antimicrob Resist 2025
Whole-genome sequencing analysis to identify antimicrobial resistance regions and virulence factors in Mycobacterium tuberculosis isolates from the Amhara Region, Ethiopia. doi:10.1038/s41598-025-01241-6 Sci Rep 2025
Tuberculosis in Malaysia: Disease timeline, epidemiology, control initiatives and outlook. Malays J Pathol 2025
The emergence of resistance to the antiparasitic selamectin in Mycobacterium smegmatis is improbable and contingent on cell wall integrity. doi:10.1128/spectrum.02332-24 Microbiol Spectr 2025
The implications of mutations in multiple genes associated with ethambutol resistance among multidrug-resistant tuberculosis isolates from China. doi:10.1186/s12866-025-03821-y BMC Microbiol 2025
Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana. doi:10.3389/fmicb.2025.1535160 Front Microbiol 2025
Disulfide bonds are required for cell division, cell envelope biogenesis and antibiotic resistance proteins in mycobacteria. doi:10.1101/2025.01.27.635063 bioRxiv 2025
Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China. doi:10.3389/fpubh.2025.1442987 Front Public Health 2025
Targeting the Heart of Mycobacterium: Advances in Anti-Tubercular Agents Disrupting Cell Wall Biosynthesis. doi:10.3390/ph18010070 Pharmaceuticals (Basel) 2025
Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis. doi:10.1002/prot.26684 Proteins 2025
Identification of potential molecular targets and repurposed drugs for tuberculosis using network-based screening approach, molecular docking, and simulation. doi:10.1080/07391102.2023.2279699 J Biomol Struct Dyn 2025
Phylogenetically Informative Mutations in Drug Resistance Genes of Human-Infecting Mycobacterium bovis. doi:10.1155/2024/5578214 Transbound Emerg Dis 2024
Mycobacterium tuberculosis evolution from monoresistance to pre-extensive drug resistance during a prolonged household outbreak. doi:10.1016/j.jctube.2024.100482 J Clin Tuberc Other Mycobact Dis 2024
Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing. doi:10.1186/s12864-024-10909-8 BMC Genomics 2024
EmbB and EmbC regulate the sensitivity of Mycobacterium abscessus to echinomycin. doi:10.1002/mlf2.12139 names it mLife 2024
Mutations in embB406 Are Associated with Low-Level Ethambutol Resistance in Canadian Mycobacterium tuberculosis Isolates. doi:10.3390/antibiotics13070624 Antibiotics (Basel) 2024
Drug-Resistant Profiles and Genetic Diversity of Mycobacterium Tuberculosis Revealed by Whole-Genome Sequencing in Hinggan League of Inner Mongolia, China. doi:10.2147/IDR.S466197 Infect Drug Resist 2024
Different Contributions of embB and ubiA Mutations to Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates. doi:10.2147/IDR.S466371 names it Infect Drug Resist 2024
Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Multidrug-Resistant Mycobacterium tuberculosis in Jiangxi, China. doi:10.2147/IDR.S460267 Infect Drug Resist 2024
Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India. doi:10.4269/ajtmh.24-0042 Am J Trop Med Hyg 2024
Identification of positively selected genes in Mycobacterium tuberculosis from southern Xinjiang Uygur autonomous region of China. doi:10.3389/fmicb.2024.1290227 Front Microbiol 2024
Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study. doi:10.3389/fmicb.2024.1349715 Front Microbiol 2024
A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools. doi:10.1371/journal.pone.0294670 PLoS One 2023
Structural dynamics insights into the M306L, M306V, and D1024N mutations in Mycobacterium tuberculosis inducing resistance to ethambutol. doi:10.5808/gi.23019 Genomics Inform 2023
Selection of Multi-Drug Targets against Drug-Resistant Mycobacterium tuberculosis XDR1219 Using the Hyperbolic Mapping of the Protein Interaction Network. doi:10.3390/ijms241814050 Int J Mol Sci 2023
Whole genome sequencing of drug resistance Mycobacterium tuberculosis from extra-pulmonary sites. doi:10.26508/lsa.202302076 Life Sci Alliance 2023
Surveillance of multidrug-resistant tuberculosis in sub-Saharan Africa through wastewater-based epidemiology. doi:10.1016/j.heliyon.2023.e18302 Heliyon 2023
Whole Genomic Analysis Revealed High Genetic Diversity and Drug-Resistant Characteristics of Mycobacterium tuberculosis in Guangxi, China. doi:10.2147/IDR.S410828 Infect Drug Resist 2023
Using Microfluidic Chip and Allele-Specific PCR to Rapidly Identify Drug Resistance-Associated Mutations of Mycobacterium tuberculosis. doi:10.2147/IDR.S410779 Infect Drug Resist 2023
Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible Mycobacterium tuberculosis clinical isolates. doi:10.4103/ijmy.ijmy_101_23 Int J Mycobacteriol 2023
Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study. doi:10.1016/j.ygeno.2023.110640 Genomics 2023
Development of DNA Bio-chip for Detection of Mutations of rpoB, embB and inhA Genes in Drug-Resistant Mycobacterium Tuberculosis. doi:10.1007/s12291-022-01044-w names it Indian J Clin Biochem 2023
A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: Applications of MassARRAY DNA mass spectrometry. doi:10.3389/fmicb.2023.1093745 Front Microbiol 2023
[The Mutations on embA, embB and embC Gene Region in Ethambutol-Resistant and Susceptible Clinical Mycobacterium tuberculosis Complex Isolates]. doi:10.5578/mb.20239904 names it Mikrobiyol Bul 2023
Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001. doi:10.3389/fcimb.2022.1056007 Front Cell Infect Microbiol 2022
Drug Resistance and Molecular Characteristics of Mycobacterium tuberculosis: A Single Center Experience. doi:10.3390/jpm12122088 J Pers Med 2022
Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil. doi:10.3389/fvets.2022.1006090 Front Vet Sci 2022
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia. doi:10.1371/journal.pone.0271508 PLoS One 2022
Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity. doi:10.7717/peerj.13645 PeerJ 2022
Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis. doi:10.1128/spectrum.02714-21 Microbiol Spectr 2022
[Exploratory study on detection of drug resistance of Mycobacterium tuberculosis in sputum specimens by next-generation sequencing]. doi:10.3760/cma.j.cn112147-20211104-00775 Zhonghua Jie He He Hu Xi Za Zhi 2022
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients. doi:10.1016/j.tube.2022.102209 Tuberculosis (Edinb) 2022
Identification of mutations in rpoB, pncA, embB, and ubiA genes among drug-resistant Mycobacterium tuberculosis clinical isolates from Iran. doi:10.1556/030.2022.01730 names it Acta Microbiol Immunol Hung 2022
Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China. doi:10.2147/IDR.S361635 Infect Drug Resist 2022
Establishment and evaluation of an overlap extension polymerase chain reaction technique for rapid and efficient detection of drug-resistance in Mycobacterium tuberculosis. doi:10.1186/s40249-022-00953-5 Infect Dis Poverty 2022
Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease. doi:10.1128/aac.02027-21 Antimicrob Agents Chemother 2022
Characterization of embB mutations involved in ethambutol resistance in multi-drug resistant Mycobacterium tuberculosis isolates in Zambia. doi:10.1016/j.tube.2022.102184 names it Tuberculosis (Edinb) 2022
Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens. doi:10.1128/spectrum.01358-21 Microbiol Spectr 2022
Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China. doi:10.1016/j.cmi.2021.09.014 Clin Microbiol Infect 2022
Abattoir survey of bovine tuberculosis in tanta, centre of the Nile delta, with in silico analysis of gene mutations and protein-protein interactions of the involved mycobacteria. doi:10.1111/tbed.14001 Transbound Emerg Dis 2022
Whole-Genome Sequencing Reveals Recent Transmission of Multidrug-Resistant Mycobacterium tuberculosis CAS1-Kili Strains in Lusaka, Zambia. doi:10.3390/antibiotics11010029 Antibiotics (Basel) 2021
DNA Methyltransferase HsdM Induce Drug Resistance on Mycobacterium tuberculosis via Multiple Effects. doi:10.3390/antibiotics10121544 Antibiotics (Basel) 2021
Whole Genome Sequencing of Drug Resistant and Drug Susceptible Mycobacterium tuberculosis Isolates From Tigray Region, Ethiopia. doi:10.3389/fmicb.2021.743198 Front Microbiol 2021
Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh. doi:10.1371/journal.pone.0261329 PLoS One 2021
Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China. doi:10.3390/antibiotics10111367 Antibiotics (Basel) 2021
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia. doi:10.1186/s12864-021-08139-3 BMC Genomics 2021
Prevalence and Molecular Characteristics Based on Whole Genome Sequencing of Mycobacterium tuberculosis Resistant to Four Anti-Tuberculosis Drugs from Southern Xinjiang, China. doi:10.2147/IDR.S320024 Infect Drug Resist 2021
Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait. doi:10.1038/s41598-021-87516-0 Sci Rep 2021
Molecular Characteristics and Drug Resistance of Mycobacterium tuberculosis Isolate Circulating in Shaanxi Province, Northwestern China. doi:10.1089/mdr.2020.0496 Microb Drug Resist 2021
Exploratory development of PCR-fluorescent probes in rapid detection of mutations associated with extensively drug-resistant tuberculosis. doi:10.1007/s10096-021-04236-z Eur J Clin Microbiol Infect Dis 2021
Molecular epidemiology of Mycobacterium tuberculosis in adult Filipino TB-HIV co-infected patients. doi:10.5588/ijtld.20.0878 Int J Tuberc Lung Dis 2021
Drug-Resistant Mycobacterium tuberculosis Isolates from New and Previously Treated TB Patients in China, 2017-2019. doi:10.1590/0037-8682-0728-2020 Rev Soc Bras Med Trop 2021
Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection. doi:10.1016/j.ijid.2021.03.033 Int J Infect Dis 2021
An explainable machine learning platform for pyrazinamide resistance prediction and genetic feature identification of Mycobacterium tuberculosis. doi:10.1093/jamia/ocaa233 J Am Med Inform Assoc 2021
Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB. doi:10.1371/journal.pone.0244829 PLoS One 2020
Rapid Detection of Ethambutol-Resistant Mycobacterium tuberculosis from Sputum by High-Resolution Melting Analysis in Beijing, China. doi:10.2147/IDR.S270542 Infect Drug Resist 2020
Frequency of Codon 306 Mutations in embB Gene of Mycobacterium tuberculosis Resistant to Ethambutol: A Systematic Review and Meta-Analysis. doi:10.4103/ijpvm.IJPVM_114_19 names it Int J Prev Med 2020
Detection of Beijing strains of MDR M. tuberculosis and their association with drug resistance mutations in katG, rpoB, and embB genes. doi:10.1186/s12879-020-05479-5 names it BMC Infect Dis 2020
Genomic Analysis Identifies Mutations Concerning Drug-Resistance and Beijing Genotype in Multidrug-Resistant Mycobacterium tuberculosis Isolated From China. doi:10.3389/fmicb.2020.01444 Front Microbiol 2020
Correlation of drug resistance with single nucleotide variations through genome analysis and experimental validation in a multi-drug resistant clinical isolate of M. tuberculosis. doi:10.1186/s12866-020-01912-6 BMC Microbiol 2020
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran. doi:10.1016/j.meegid.2020.104468 Infect Genet Evol 2020
Cryo-EM structure of arabinosyltransferase EmbB from Mycobacterium smegmatis. doi:10.1038/s41467-020-17202-8 names it Nat Commun 2020
Rapidly Correcting Frameshift Mutations in the Mycobacterium tuberculosis orn Gene Produce Reversible Ethambutol Resistance and Small-Colony-Variant Morphology. doi:10.1128/AAC.00213-20 Antimicrob Agents Chemother 2020
Genomic signatures of drug resistance in highly resistant Mycobacterium tuberculosis strains of the early ancient sublineage of Beijing genotype in Russia. doi:10.1016/j.ijantimicag.2020.106036 Int J Antimicrob Agents 2020
Detecting Ethambutol Resistance in Mycobacterium tuberculosis Isolates in China: A Comparison Between Phenotypic Drug Susceptibility Testing Methods and DNA Sequencing of embAB. doi:10.3389/fmicb.2020.00781 Front Microbiol 2020
[Analysis on drug resistance-associated mutations of multi-drug resistant Mycobacterium tuberculosis based on whole-genome sequencing in China]. doi:10.3760/cma.j.cn112338-20191111-00800 Zhonghua Liu Xing Bing Xue Za Zhi 2020
Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears. doi:10.1371/journal.pone.0232343 PLoS One 2020
Cryo-EM snapshots of mycobacterial arabinosyltransferase complex EmbB(2)-AcpM(2). doi:10.1007/s13238-020-00726-6 names it Protein Cell 2020
Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol. doi:10.1126/science.aba9102 Science 2020
Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France. doi:10.1016/j.ijantimicag.2020.105912 Int J Antimicrob Agents 2020
The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey. doi:10.1080/1120009X.2020.1716477 J Chemother 2020
Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing. doi:10.1038/s41598-020-57992-x Sci Rep 2020
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. doi:10.1186/s40001-019-0397-2 Eur J Med Res 2019
Antibiotic resistance of Mycobacterium tuberculosis complex in Africa: A systematic review of current reports of molecular epidemiology, mechanisms and diagnostics. doi:10.1016/j.jinf.2019.10.006 J Infect 2019
Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan. doi:10.1038/s41598-019-51562-6 Sci Rep 2019
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. doi:10.2147/IDR.S209971 Infect Drug Resist 2019
Whole-genome sequencing-based epidemiological analysis of anti-tuberculosis drug resistance genes in Japan in 2007: Application of the Genome Research for Asian Tuberculosis (GReAT) database. doi:10.1038/s41598-019-49219-5 Sci Rep 2019
Diagnostic predictive values of the Hain genotype MTBDRsl assay in mycobacterial strains isolated from Sudan. doi:10.11604/pamj.2019.32.124.12762 Pan Afr Med J 2019
Distribution of embB mutations of Thai clinical isolates of ethambutol-resistant Mycobacterium tuberculosis. doi:10.1016/j.jgar.2019.05.033 names it J Glob Antimicrob Resist 2019
WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. doi:10.1093/jac/dkz215 J Antimicrob Chemother 2019
First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria. doi:10.1016/j.jgar.2019.05.010 J Glob Antimicrob Resist 2019
Rapid screening mutations of first-line-drug-resistant genes in Mycobacterium tuberculosis strains by allele-specific real-time quantitative PCR. doi:10.7717/peerj.6696 PeerJ 2019
Lack of association of novel mutation Asp397Gly in aftB gene with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis. doi:10.1016/j.tube.2019.01.004 Tuberculosis (Edinb) 2019
Characterization of the most common embCAB gene mutations associated with ethambutol resistance in Mycobacterium tuberculosis isolates from Iran. doi:10.2147/IDR.S196800 Infect Drug Resist 2019
A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis. doi:10.1038/s41598-019-39339-3 Sci Rep 2019
Drug repurposing against arabinosyl transferase (EmbC) of Mycobacterium tuberculosis: Essential dynamics and free energy minima based binding mechanics analysis. doi:10.1016/j.gene.2019.01.029 Gene 2019
Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle. doi:10.1016/j.tube.2018.12.005 Tuberculosis (Edinb) 2019
Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation. doi:10.1186/s12941-018-0300-y Ann Clin Microbiol Antimicrob 2019
A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting. doi:10.1128/AAC.01798-18 Antimicrob Agents Chemother 2019
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia. doi:10.1016/j.jgar.2018.08.018 J Glob Antimicrob Resist 2019
The relationship between embb306 and embb406 mutations and ethambutol resistant in Mycobacterium tuberculosis isolated from patiens in west of Iran. doi:10.14196/mjiri.32.117 Med J Islam Repub Iran 2018
New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe. doi:10.1186/s12864-018-5162-3 BMC Genomics 2018
Evaluation of Genotype MTBDRplus and MTBDRsl Assays for Rapid Detection of Drug Resistance in Extensively Drug-Resistant Mycobacterium tuberculosis Isolates in Pakistan. doi:10.3389/fmicb.2018.02265 Front Microbiol 2018
Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China. doi:10.2147/IDR.S176609 Infect Drug Resist 2018
Relapse Versus Reinfection of Recurrent Tuberculosis Patients in a National Tuberculosis Specialized Hospital in Beijing, China. doi:10.3389/fmicb.2018.01858 Front Microbiol 2018
Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines. doi:10.1016/j.jgar.2018.08.009 J Glob Antimicrob Resist 2018
Rapid detection of ethambutol-resistant Mycobacterium tuberculosis in clinical specimens by real-time polymerase chain reaction hybridisation probe method. doi:10.4103/ijmm.IJMM_14_304 Indian J Med Microbiol 2018
The singular Corynebacterium glutamicum Emb arabinofuranosyltransferase polymerises the α(1 → 5) arabinan backbone in the early stages of cell wall arabinan biosynthesis. doi:10.1016/j.tcsw.2018.06.003 Cell Surf 2018
Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania. doi:10.1038/s41598-018-27962-5 Sci Rep 2018
TB-EFI, a novel 18-Plex microbead-based method for prediction of second-line drugs and ethambutol resistance in Mycobacterium tuberculosis complex. doi:10.1016/j.mimet.2018.06.003 J Microbiol Methods 2018
Efficient synthesis of a linear octyl pentaarabinofuranoside, a substrate for mycobacterial EmbA/EmbB proteins. doi:10.1016/j.carres.2018.05.009 names it Carbohydr Res 2018
Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates. doi:10.3343/alm.2018.38.4.316 Ann Lab Med 2018
Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania. doi:10.1016/j.tube.2018.02.004 Tuberculosis (Edinb) 2018
Polymorphisms in Rv3806c (ubiA) and the upstream region of embA in relation to ethambutol resistance in clinical isolates of Mycobacterium tuberculosis from North India. doi:10.1016/j.tube.2017.10.003 Tuberculosis (Edinb) 2018
Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates. doi:10.1128/JCM.01214-17 J Clin Microbiol 2018
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii. doi:10.1128/AAC.01788-17 Antimicrob Agents Chemother 2018
Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol. doi:10.1089/mdr.2017.0294 Microb Drug Resist 2018
Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing. doi:10.1016/j.mimet.2017.12.003 J Microbiol Methods 2018
Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context. doi:10.1093/jac/dkx372 J Antimicrob Chemother 2018
Mutations within embCAB Are Associated with Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates from China. doi:10.1128/AAC.01279-17 Antimicrob Agents Chemother 2018
High Resolution Melting Curve Analysis for Rapid Detection of Streptomycin and Ethambutol Resistance in Mycobacterium tuberculosis. Maedica (Bucur) 2017
Comparative Genomic Analysis of Two Clonally Related Multidrug Resistant Mycobacterium tuberculosis by Single Molecule Real Time Sequencing. doi:10.3389/fcimb.2017.00478 Front Cell Infect Microbiol 2017
Mutation analysis for detection of drug resistance in mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan. J Pak Med Assoc 2017
Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa. doi:10.1007/s12041-017-0805-8 J Genet 2017
An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs). doi:10.1371/journal.pone.0183561 PLoS One 2017
Comparison of semi-automated commercial rep-PCR fingerprinting, spoligotyping, 12-locus MIRU-VNTR typing and single nucleotide polymorphism analysis of the embB gene as molecular typing tools for Mycobacterium bovis. doi:10.1099/jmm.0.000536 names it J Med Microbiol 2017
Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV co-infected patients in Ho Chi Minh city, Vietnam. doi:10.1016/j.jgar.2017.07.003 J Glob Antimicrob Resist 2017
A comparative study of phenotypic and genotypic first- and second-line drug resistance testing of Mycobacterium tuberculosis. doi:10.1016/j.biologicals.2017.07.003 Biologicals 2017
Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan. doi:10.1016/j.micpath.2017.07.005 Microb Pathog 2017
Screening mutations in drug-resistant Mycobacterium tuberculosis strains in Yunnan, China. doi:10.1016/j.jiph.2017.04.008 J Infect Public Health 2017
Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis. doi:10.1371/journal.pone.0176522 PLoS One 2017
Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014. doi:10.37757/MR2017.V19.N1.3 MEDICC Rev 2017
Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes? doi:10.1016/j.meegid.2017.02.012 Infect Genet Evol 2017
FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance. doi:10.1128/JCM.01662-16 J Clin Microbiol 2017
Engineering Mycobacteria for the Production of Self-Assembling Biopolyesters Displaying Mycobacterial Antigens for Use as a Tuberculosis Vaccine. doi:10.1128/AEM.02289-16 Appl Environ Microbiol 2017
Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China. doi:10.1371/journal.pone.0169413 PLoS One 2017
Ethambutol-resistance testing by mutation detection using MTBDRsl. doi:10.1016/j.ijmyco.2016.06.007 Int J Mycobacteriol 2016
Mutations in embB gene associated with resistance to ethambutol in Mycobacterium tuberculosis strains isolated from TB patients in the west of Iran (2014-15). doi:10.1016/j.ijmyco.2016.11.013 names it Int J Mycobacteriol 2016
A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia. doi:10.1371/journal.pone.0167093 PLoS One 2016
Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. doi:10.1186/s12879-016-1906-3 BMC Infect Dis 2016
Association between embB Codon 306 Mutations, Phenotypic Resistance Profiles, and Genotypic Characterization in Clinical Mycobacterium tuberculosis Isolates from Hebei, China. doi:10.1128/AAC.00532-16 names it Antimicrob Agents Chemother 2016
Genotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012. doi:10.1186/s12866-016-0786-4 BMC Microbiol 2016
Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States. doi:10.1155/2016/3404860 Tuberc Res Treat 2016
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. doi:10.1186/s12866-016-0699-2 BMC Microbiol 2016
Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.03002-15 Antimicrob Agents Chemother 2016
Frequency of mutational changes in the embB among the ethambutol-resistant strains of Mycobacterium tuberculosis in Iran. doi:10.3855/jidc.7215 names it J Infect Dev Ctries 2016
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance. doi:10.1186/s12916-016-0575-9 BMC Med 2016
Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray. doi:10.1093/jac/dkw015 J Antimicrob Chemother 2016
Molecular characterization and drug susceptibility profile of a Mycobacterium avium subspecies avium isolate from a dog with disseminated infection. doi:10.1099/jmm.0.000221 J Med Microbiol 2016
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement. doi:10.5588/ijtld.15.0221 Int J Tuberc Lung Dis 2016
The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae. doi:10.1016/j.ijmyco.2015.05.001 Int J Mycobacteriol 2015
Performance Assessment of the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method for Rapid Detection of Susceptibility to Ethambutol and Molecular Prediction of Extensively Drug-resistant Tuberculosis in Clinical Isolates of Mycobacterium tuberculosis. doi:10.7727/wimj.2014.022 West Indian Med J 2015
Genome sequence comparisons of serial multi-drug-resistant Mycobacterium tuberculosis isolates over 21 years of infection in a single patient. doi:10.1099/mgen.0.000037 Microb Genom 2015
Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China. doi:10.1155/2015/951706 Biomed Res Int 2015
Pyrosequencing analysis for mutations in embB codon306 among clinical mycobacterium tuberculosis isolates from Qingdao, China. names it Int J Clin Exp Med 2015
Pyrosequencing for rapid detection of Mycobacterium tuberculosis second-line drugs and ethambutol resistance. doi:10.1016/j.diagmicrobio.2015.07.004 Diagn Microbiol Infect Dis 2015
Mutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis. doi:10.1128/AAC.00117-15 names it Antimicrob Agents Chemother 2015
Mutations at embB306 codon and their association with multidrug resistant M. tuberculosis clinical isolates. doi:10.4103/0255-0857.158560 Indian J Med Microbiol 2015
Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation. doi:10.1371/journal.pone.0129207 PLoS One 2015
Molecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France. doi:10.1128/AAC.00150-15 Antimicrob Agents Chemother 2015
Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan. doi:10.1371/journal.pone.0117771 PLoS One 2015
Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes. doi:10.1128/mBio.02273-14 mBio 2015
Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China. doi:10.1128/AAC.04933-14 Antimicrob Agents Chemother 2015
Multiple drug-susceptibility screening in Mycobacterium bovis: new nucleotide polymorphisms in the embB gene among ethambutol susceptible strains. doi:10.1016/j.ijid.2014.12.043 names it Int J Infect Dis 2015
ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis. doi:10.1016/j.tube.2014.12.002 Tuberculosis (Edinb) 2015
Evolution and transmission patterns of extensively drug-resistant tuberculosis in China. doi:10.1128/AAC.03504-14 Antimicrob Agents Chemother 2015
A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland. doi:10.1007/s10096-014-2202-z Eur J Clin Microbiol Infect Dis 2015
[Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis]. Pneumologia 2014
Mutations in the essential arabinosyltransferase EmbC lead to alterations in Mycobacterium tuberculosis lipoarabinomannan. doi:10.1074/jbc.M114.583112 J Biol Chem 2014
Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960. doi:10.1371/journal.pone.0108911 PLoS One 2014
Mutations in the embC-embA intergenic region contribute to Mycobacterium tuberculosis resistance to ethambutol. doi:10.1128/AAC.03285-14 Antimicrob Agents Chemother 2014
Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China. doi:10.1111/tmi.12359 Trop Med Int Health 2014
Diagnostic accuracy of a molecular drug susceptibility testing method for the antituberculosis drug ethambutol: a systematic review and meta-analysis. doi:10.1128/JCM.00560-14 J Clin Microbiol 2014
Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon. doi:10.1186/1471-2180-14-113 BMC Microbiol 2014
Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array-authors' response. doi:10.1093/jac/dku134 names it J Antimicrob Chemother 2014
Comment on: characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array. doi:10.1093/jac/dku101 names it J Antimicrob Chemother 2014
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China. doi:10.1128/AAC.02426-14 Antimicrob Agents Chemother 2014
Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients. doi:10.1186/1471-2334-14-200 BMC Infect Dis 2014
Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis. doi:10.1128/JCM.00238-14 J Clin Microbiol 2014
Deciphering the sequential events during in vivo acquisition of drug resistance in Mycobacterium tuberculosis. doi:10.1016/j.ijmyco.2013.10.006 Int J Mycobacteriol 2014
Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. doi:10.1128/JCM.02713-13 names it J Clin Microbiol 2014
A rapid fluorescence polarization-based method for genotypic detection of drug resistance in Mycobacterium tuberculosis. doi:10.1007/s00253-013-5356-1 Appl Microbiol Biotechnol 2014
Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array. doi:10.1093/jac/dkt448 names it J Antimicrob Chemother 2014
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis. doi:10.1093/jac/dkt358 J Antimicrob Chemother 2014
Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland. doi:10.1155/2013/167954 names it Biomed Res Int 2013
Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation. doi:10.3201/eid1910.121108 Emerg Infect Dis 2013
Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopia. doi:10.7150/ijms.6806 Int J Med Sci 2013
Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania. doi:10.1186/1471-2334-13-432 BMC Infect Dis 2013
Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay. doi:10.4103/0022-3859.118034 J Postgrad Med 2013
Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes. doi:10.1038/ng.2743 Nat Genet 2013
High resolution melting curve assay for rapid detection of drug-resistant Mycobacterium tuberculosis. doi:10.1007/s10156-013-0636-3 J Infect Chemother 2013
Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia. doi:10.1128/JCM.00429-13 J Clin Microbiol 2013
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. doi:10.1016/j.diagmicrobio.2013.02.035 Diagn Microbiol Infect Dis 2013
Association between embB mutations and ethambutol resistance in Mycobacterium tuberculosis isolates from Cuba and the Dominican Republic: reproducible patterns and problems. names it Rev Argent Microbiol 2013
Evidence for diversifying selection in a set of Mycobacterium tuberculosis genes in response to antibiotic- and nonantibiotic-related pressure. doi:10.1093/molbev/mst038 Mol Biol Evol 2013
Simple and rapid discrimination of embB codon 306 mutations in Mycobacterium tuberculosis clinical isolates by a real-time PCR assay using an LNA-TaqMan probe. doi:10.1016/j.mimet.2012.12.014 names it J Microbiol Methods 2013
[Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol]. Kekkaku 2012
embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis. doi:10.1159/000343474 Chemotherapy 2012
Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. doi:10.1164/rccm.201205-0960OC Am J Respir Crit Care Med 2012
[A rapid screening program on the resistance to streptomycin and ethambutol in Mycobacterium tuberculosis isolates by PCR melting curve analysis]. Zhonghua Liu Xing Bing Xue Za Zhi 2012
Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. doi:10.1186/1471-2180-12-90 BMC Microbiol 2012
Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing. doi:10.1128/JCM.06664-11 J Clin Microbiol 2012
Drug resistance of Mycobacterium tuberculosis strains in southern Brazil. doi:10.1590/s0037-86822012000100018 Rev Soc Bras Med Trop 2012
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. doi:10.1186/1471-2334-12-37 BMC Infect Dis 2012
Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. doi:10.5588/ijtld.10.0600 Int J Tuberc Lung Dis 2012
The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services. doi:10.5588/ijtld.11.0223 Int J Tuberc Lung Dis 2012
Correlation of the phenotypic ethambutol susceptibility of Mycobacterium tuberculosis with embB gene mutations in Korea. doi:10.1099/jmm.0.037614-0 names it J Med Microbiol 2012
Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China. doi:10.1093/jac/dkr284 names it J Antimicrob Chemother 2011
Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1111/j.1574-695X.2011.00814.x FEMS Immunol Med Microbiol 2011
Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. doi:10.1128/JCM.00197-11 J Clin Microbiol 2011
Mycobacterium tuberculosis embB codon 306 mutations confer moderately increased resistance to ethambutol in vitro and in vivo. doi:10.1128/AAC.00007-10 names it Antimicrob Agents Chemother 2011
Rapid detection of ethambutol-resistant Mycobacterium tuberculosis directly from sputum samples by radioisotope (32P)-based PCR dot blot hybridization and sequencing methods. Acta Med Indones 2011
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. doi:10.1128/AAC.01550-10 Antimicrob Agents Chemother 2011
[Correlation between ethambutol-resistance and embB gene mutation in Mycobacterium tuberculosis]. names it Wei Sheng Yan Jiu 2010
Molecular characterization of drug-resistant Beijing family isolates of Mycobacterium tuberculosis from Tianjin, China. doi:10.1016/S0895-3988(10)60051-7 Biomed Environ Sci 2010
One-tube loop-mediated isothermal amplification combined with restriction endonuclease digestion and ELISA for colorimetric detection of resistance to isoniazid, ethambutol and streptomycin in Mycobacterium tuberculosis isolates. doi:10.1016/j.mimet.2010.07.018 J Microbiol Methods 2010
embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. doi:10.1093/jac/dkq120 J Antimicrob Chemother 2010
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. doi:10.1128/JCM.01947-09 J Clin Microbiol 2010
Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study. Int J Tuberc Lung Dis 2010
Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis. doi:10.1128/AAC.01288-09 Antimicrob Agents Chemother 2010
Clinical efficacy of direct DNA sequencing analysis on sputum specimens for early detection of drug-resistant Mycobacterium tuberculosis in a clinical setting. doi:10.1378/chest.09-0150 Chest 2010
Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. doi:10.3855/jidc.125 J Infect Dev Ctries 2009
The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis. doi:10.1128/AAC.00162-09 Antimicrob Agents Chemother 2009
[Detection of mutations in codon 306 of the embB gene for molecular genetic characterization of clinical Mycobacterium tuberculosis strains]. names it Probl Tuberk Bolezn Legk 2009
[Molecular characterization of embB306 gene in Mycobacterium tuberculosis isolates from tuberculosis patients in Chongqing municipality]. Zhonghua Yu Fang Yi Xue Za Zhi 2009
Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression. doi:10.1371/journal.pone.0005923 PLoS One 2009
Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait. doi:10.1186/1476-0711-8-2 Ann Clin Microbiol Antimicrob 2009
Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. doi:10.1016/j.ijid.2008.10.006 Int J Infect Dis 2009
Molecular detection of drug-resistant Mycobacterium tuberculosis with a scanning-frame oligonucleotide microarray. doi:10.1007/978-1-59745-207-6_26 Methods Mol Biol 2009
Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.01357-08 names it Antimicrob Agents Chemother 2009
Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations. doi:10.1016/j.ijantimicag.2008.09.021 Int J Antimicrob Agents 2009
emb nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol. doi:10.1016/j.ijmm.2008.07.001 Int J Med Microbiol 2009
Novel mutations in emb B gene of ethambutol resistant isolates of Mycobacterium tuberculosis: a preliminary report. Indian J Med Res 2008
Phenotypic and genotypic characterization of drug-resistant Mycobacterium tuberculosis strains. doi:10.1016/j.diagmicrobio.2008.06.013 Diagn Microbiol Infect Dis 2008
Molecular characterization of drug-resistant mycobacterium tuberculosis isolates from Sichuan Province in china. Jpn J Infect Dis 2008
Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1-->3) arabinofuranosyltransferase. doi:10.1111/j.1365-2958.2008.06354.x Mol Microbiol 2008
Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis. doi:10.1128/AAC.00309-08 Antimicrob Agents Chemother 2008
Transfer of the first arabinofuranose residue to galactan is essential for Mycobacterium smegmatis viability. doi:10.1128/JB.00028-08 J Bacteriol 2008
Varying prevalence of embB codon 306 mutations in ethambutol-resistant clinical Mycobacterium tuberculosis isolates from Beirut and Dubai. doi:10.1179/joc.2008.20.2.285 names it J Chemother 2008
Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. doi:10.1128/AAC.01486-07 names it Antimicrob Agents Chemother 2008
EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis. doi:10.1099/mic.0.2007/012153-0 Microbiology (Reading) 2008
Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis. doi:10.1128/JCM.01821-07 J Clin Microbiol 2008
Drug susceptibility of Spanish Mycobacterium tuberculosis complex isolates from animals. doi:10.1016/j.tube.2007.08.004 Tuberculosis (Edinb) 2007
Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China. doi:10.1128/AAC.00416-07 names it Antimicrob Agents Chemother 2007
Molecular investigation of recurrent tuberculosis in patients from Rwanda. Int J Tuberc Lung Dis 2007
Characterization of a distinct arabinofuranosyltransferase in Mycobacterium smegmatis. doi:10.1021/ja070330k J Am Chem Soc 2007
Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.01516-06 names it Antimicrob Agents Chemother 2007
Identification of a novel arabinofuranosyltransferase AftB involved in a terminal step of cell wall arabinan biosynthesis in Corynebacterianeae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. doi:10.1074/jbc.M700271200 J Biol Chem 2007
Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. doi:10.1093/jac/dkm054 J Antimicrob Chemother 2007
Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. doi:10.1016/j.tube.2006.05.004 names it Tuberculosis (Edinb) 2007
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates recovered from central China. doi:10.1007/s10528-006-9074-6 Biochem Genet 2007
Detection of multidrug resistance in Mycobacterium tuberculosis. doi:10.1128/JCM.00750-06 J Clin Microbiol 2007
Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis. doi:10.1093/glycob/cwl066 Glycobiology 2007
[Analysis of ethambutol drug-resistance gene mutation in Mycobacterium tuberculosis by specific endonuclease]. Zhonghua Jie He He Hu Xi Za Zhi 2006
Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis. doi:10.1007/s00284-006-0135-1 Curr Microbiol 2006
Arabinan-deficient mutants of Corynebacterium glutamicum and the consequent flux in decaprenylmonophosphoryl-D-arabinose metabolism. doi:10.1093/glycob/cwl030 Glycobiology 2006
Characterization of a specific arabinosyltransferase activity involved in mycobacterial arabinan biosynthesis. doi:10.1016/j.chembiol.2006.05.016 Chem Biol 2006
The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the arabinan in lipoarabinomannan. doi:10.1074/jbc.M513846200 J Biol Chem 2006
Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. doi:10.1128/AAC.50.5.1900-1902.2006 names it Antimicrob Agents Chemother 2006
Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. doi:10.1074/jbc.M600045200 J Biol Chem 2006
Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 2006
Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. doi:10.1016/j.micinf.2005.06.008 Microbes Infect 2006
Detection and evaluation of the mutations of embB gene in ethambutol-susceptible and resistant Mycobacterium tuberculosis isolates from China. names it Chin Med J (Engl) 2005
[Resistance to antituberculous drugs]. doi:10.1016/s0929-693x(05)80024-7 Arch Pediatr 2005
Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. doi:10.1128/AAC.49.9.3794-3802.2005 names it Antimicrob Agents Chemother 2005
Deletion of Cg-emb in corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an arabinan-deficient mutant with a cell wall galactan core. doi:10.1074/jbc.M506339200 J Biol Chem 2005
[Anti-drug pattern of drug-resistant Mycobacterium tuberculosis and analysis of mutation in drug-target genes]. doi:10.11150/kansenshogakuzasshi1970.79.388 Kansenshogaku Zasshi 2005
Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. doi:10.1128/AAC.49.6.2218-2225.2005 Antimicrob Agents Chemother 2005
A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. doi:10.1016/j.mimet.2005.02.004 J Microbiol Methods 2005
Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005
Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan. doi:10.1074/jbc.M411418200 J Biol Chem 2005
Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed. doi:10.1093/glycob/cwh150 Glycobiology 2005
Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. doi:10.1016/j.resmic.2004.06.007 names it Res Microbiol 2004
Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. doi:10.1128/JCM.42.11.5277-5285.2004 J Clin Microbiol 2004
Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. doi:10.1128/AAC.48.11.4447-4449.2004 names it Antimicrob Agents Chemother 2004
[Molecular identification of mycobacteria and detection of antibiotic resistance]. Ann Biol Clin (Paris) 2004
Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations. doi:10.1016/j.mcp.2004.04.001 names it Mol Cell Probes 2004
Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. doi:10.1086/421501 J Infect Dis 2004
Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.mimet.2004.02.006 J Microbiol Methods 2004
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. doi:10.1099/jmm.0.05343-0 J Med Microbiol 2004
The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. doi:10.1046/j.1365-2958.2003.03681.x Mol Microbiol 2003
[Clinical application and evaluation of the detection of five drugs resistance genes in Mycobacterium tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2002
Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing. doi:10.1128/JCM.40.10.3810-3813.2002 J Clin Microbiol 2002
Reference to the mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol. doi:10.3349/ymj.2002.43.4.556 names it Yonsei Med J 2002
Molecular analysis of clinical isolates of Mycobacterium tuberculosis collected from patients with persistent disease in the Khartoum region of Sudan. doi:10.1053/jinf.2001.0992 J Infect 2002
Detection of ethambutol-resistant Mycobacterium tuberculosis strains by multiplex allele-specific PCR assay targeting embB306 mutations. doi:10.1128/JCM.40.5.1617-1620.2002 J Clin Microbiol 2002
Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms. doi:10.1128/JCM.40.5.1610-1616.2002 J Clin Microbiol 2002
Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol. doi:10.3349/ymj.2002.43.1.59 names it Yonsei Med J 2002
The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. doi:10.1074/jbc.M102272200 names it J Biol Chem 2001
Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt. doi:10.1128/JCM.39.6.2330-2334.2001 J Clin Microbiol 2001
Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2001
Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach. doi:10.1006/mcpr.2000.0339 names it Mol Cell Probes 2001
[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis]. doi:10.7888/juoeh.22.269 J UOEH 2000
Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. doi:10.1128/AAC.44.2.326-336.2000 Antimicrob Agents Chemother 2000
Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. doi:10.1054/tuld.1999.0222 Tuber Lung Dis 1999
Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. doi:10.1054/tuld.1998.0013 Tuber Lung Dis 1998
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. doi:10.1054/tuld.1998.0002 Tuber Lung Dis 1998
[Mechanisms of drug-resistance in mycobacteria]. Nihon Rinsho 1998
[Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in Mycobacterium tuberculosis--genetic mechanisms of drug-resistance]. Kekkaku 1998
Molecular techniques in the diagnosis of drug-resistant tuberculosis. Ann Acad Med Singap 1997
[Rapid diagnosis of tuberculosis]. Kekkaku 1997
A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis. doi:10.1128/AAC.41.12.2629 names it Antimicrob Agents Chemother 1997
Role of embB in natural and acquired resistance to ethambutol in mycobacteria. doi:10.1128/AAC.41.10.2270 names it Antimicrob Agents Chemother 1997
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. doi:10.1128/AAC.41.8.1677 names it Antimicrob Agents Chemother 1997
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. doi:10.1038/nm0597-567 Nat Med 1997
The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. doi:10.1073/pnas.93.21.11919 Proc Natl Acad Sci U S A 1996

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourembA (Rv3794, + strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index -5.84 (95% CI -6.31 to -5.42). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in the biosynthesis of the mycobacterial cell wall arabinan and resistance to ethambutol (EMB; dextro-2,2'-(ethylenediimino)-DI-1-butanol). Polymerizes arabinose into the arabinan of arabiogalactan [catalytic activity: UDP-L-arabinose + indol-3-ylacetyl-myo-inositol = UDP + indol-3-ylacetyl-myo-inositol L-arabinoside].
Mycobrowser EC 2.4.2.- · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3824 · 99.8% identity
M. leprae ML0104c · 78.9% identity
M. marinum MMAR_5357 · 88.6% identity
M. smegmatis MSMEG_6389 · 68.8% identity
M. orygis RJtmp_003907 · 99.9% identity
M. abscessus MAB_0185c · 67.0% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WNL7 SwissProt · reviewed · Evidence at protein level
UniProt nameProbable arabinosyltransferase B
EC (curated) EC 2.4.2.-
Curated functionArabinosyl transferase responsible for the polymerization of arabinose into the arabinan of arabinogalactan.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category M Cell wall / membrane / envelope biogenesis
Preferred nameembB
eggNOG descriptionCell wall arabinan synthesis protein
Orthologous groupCOG1807
KEGG orthology K11386, K11387
Gene Ontology (10) GO:0005575, GO:0005618, GO:0005623, GO:0005886, GO:0008150, GO:0016020, GO:0030312, GO:0040007, GO:0044464, GO:0071944

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.995 · relaxed/neutral
Polymorphic sites (≥ 0.1% of strains) 11 synonymous, 30 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Corynebacteriales

M. canettii dN/dS (deep-divergence selection) 0.209 · 11 consensus substitution(s)
under purifying selection vs M. canettii (deep divergence; dN/dS=0.209) — a real, constrained gene predating the MTBC clonal expansion
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 83.1% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 7/13 non-Mycobacterium reference genomes (down to Corynebacteriales) · mean identity 46.6%
detected across the order Corynebacteriales (Corynebacterium/Nocardia/Rhodococcus/…) but not in more distant Actinomycetia — a Corynebacteriales-level gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 50 in the ORF — 49 in the essential state, 0 growth-defect, 1 non-essential, 0 growth-advantage. Saturation 0.020, mean read count 128. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 50 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Drug resistance (WHO catalogue) ethambutol

ethambutol33 catalogued resistance-associated variant(s)

This gene carries mutations classed Associated with resistance (WHO grade 1–2) in the consolidated catalogue (WHO 2nd ed. 2023 + tb-profiler). Only the R-associated tier is shown; "uncertain" and empirical-only signals are excluded. Test a specific strain or variant with the resistance tester. Research context, not a clinical diagnostic.

Proteomics (mass spectrometry) detected

MS detectiondetected in 12 of 16 independent MS datasets
Integrated abundance60.2 ppm · rank 1633/3519 (53.6th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox)

Predictionpredicted membrane protein (15 TM helixes)
DeepTMHMM classTM
TM helices (DeepTMHMM)15

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length1098 aa
Molecular weight118.0 kDa
Theoretical pI9.61
GRAVY0.309 (hydrophobic)
Aliphatic index99.9
Aromaticity0.094
Instability index37.1 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Arabino_trans_NPF17689.9 8.0e-5451–209 Arabinosyltransferase concanavalin like domain
Arabinose_transPF04602.19 2.4e-195214–688 Mycobacterial cell wall arabinan synthesis protein
Arabino_trans_CPF14896.13 3.4e-134719–1095 EmbC C-terminal domain

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 7bvf (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 1 solved

PDBMethodResolutionCoverage
7bvf Electron Microscopy 2.97 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (1 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 92.7

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
7bvf-assembly1_B 1.00 0.99 0.95 0.99 98% 98% / 100% 0.0e+00 sig 7bvf-assembly1_B Cryo-EM structure of Mycobacterium tuberculosis arabinosyltransferase EmbA-EmbB-AcpM2 in complex with ethambutol
7bvg-assembly1_B 1.00 0.98 0.95 0.98 69% 98% / 100% 0.0e+00 sig 7bvg-assembly1_B Cryo-EM structure of Mycobacterium smegmatis arabinosyltransferase EmbA-EmbB-AcpM2 in complex with di-arabinose.
6x0o-assembly1_A 1.00 0.98 0.92 0.98 67% 98% / 100% 0.0e+00 sig 6x0o-assembly1_A Single-Particle Cryo-EM Structure of Arabinosyltransferase EmbB from Mycobacterium smegmatis
7bwr-assembly1_A 1.00 0.97 0.94 0.97 69% 98% / 100% 0.0e+00 sig 7bwr-assembly1_A Mycobacterium smegmatis arabinosyltransferase complex EmbB2-AcpM2 in substrate DPA bound asymmetric "active state"
7bx8-assembly1_B 1.00 0.98 0.92 0.98 67% 98% / 100% 0.0e+00 sig 7bx8-assembly1_B Mycobacterium smegmatis arabinosyltransferase complex EmbB2-AcpM2 in symmetric "resting state"

Foldseek search of the AlphaFold DB model (mean pLDDT 92.7, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 2

Upstream (5' on genome)embA (+ strand, -4 bp gap)
Downstream (3' on genome)Rv3796 (+ strand, 67 bp gap)
Predicted operon embA · embB

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 3: embC · embA · embB — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3902) exponential phase: operon of 2, Rv3794 · Rv3795 (coverage 19.74)
not expressed (stationary phase) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) Rv0302 (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: embA (arabinosyltransferase A), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair rests on an interaction measured in M. tuberculosis itself (own experimental score 900): a measured association in this organism, as opposed to one carried over from other proteomes. This partner is also a paralogue of this gene (STRING homology score 876), so the association may reflect shared ancestry rather than a shared pathway.

Showing the 15 strongest of this gene's 120 partners at medium confidence (34 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. Of the 120 partners, 2 rest on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3794 embA measured in Mtb curated paralog arabinosyltransferase A 999 1000 ctx neighborhood:881 coexpression:798 experimental:999 database:900
Rv2244 acpM measured in Mtb meromycolate extension acyl carrier protein 999 999 experimental:999
Rv3792 aftA curated arabinofuranosyltransferase 995 953 ctx neighborhood:580 cooccurence:755 database:500 textmining:900
Rv3791 dprE2 curated decaprenylphosphoryl-D-2-keto erythropentose reductase 913 887 ctx neighborhood:580 cooccurence:493 database:500
Rv2673 aftC curated alpha-(1->3)-arabinofuranosyltransferase 947 882 ctx cooccurence:765 database:500 textmining:568
Rv3789 GtrA family protein 874 860 ctx neighborhood:503 cooccurence:726
Rv3802c membrane protein 805 806 ctx cooccurence:771
Rv3805c aftB terminal beta-(1->2)-arabinofuranosyltransferase 948 797 ctx cooccurence:758 textmining:757
Rv3790 dprE1 decaprenylphosphoryl-beta-D-ribose oxidase 852 788 ctx neighborhood:580 cooccurence:493
Rv3244c lpqB lipoprotein LpqB 753 754 ctx cooccurence:750
Rv1476 membrane protein 751 752 ctx cooccurence:750
Rv3438 hypothetical protein 742 742 ctx cooccurence:735
Rv0996 transmembrane protein 734 735 ctx cooccurence:734
Rv0358 hypothetical protein 729 730 ctx cooccurence:728
Rv3793 embC paralog arabinosyltransferase C 751 727 ctx neighborhood:612

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: arabinosyltransferase B
  • MTBC0 PGAP product: arabinosyltransferase EmbB
  • Pfam (hmmscan --cut_ga): Arabino_trans_N PF17689.9 (E=8e-54), Arabinose_trans PF04602.19 (E=2e-195), Arabino_trans_C PF14896.13 (E=3e-134)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_218312.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Arabino_trans_N (PF17689.9), Arabinose_trans (PF04602.19), Arabino_trans_C (PF14896.13)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG1807
  • Curated reference: UniProt P9WNL7 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 92.7)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 120 functional partner(s); context anchor embA
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Drug resistance: consolidated catalogue, WHO 2nd ed. 2023 (9789240082410) + tb-profiler; only the resistance-associated tier (grade 1–2) is surfaced
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_004023|Rv3795|embB
MTQCASRRKSTPNRAILGAFASARGTRWVATIAGLIGFVLSVATPLLPVVQTTAMLDWPQRGQLGSVTAPLISLTPVDFTATVPCDVVRAMPPAGGVVLGTAPKQGKDANLQALFVVVSAQRVDVTDRNVVILSVPREQVTSPQCQRIEVTSTHAGTFANFVGLKDPSGAPLRSGFPDPNLRPQIVGVFTDLTGPAPPGLAVSATIDTRFSTRPTTLKLLAIIGAIVATVVALIALWRLDQLDGRGSIAQLLLRPFRPASSPGGMRRLIPASWRTFTLTDAVVIFGFLLWHVIGANSSDDGYILGMARVADHAGYMSNYFRWFGSPEDPFGWYYNLLALMTHVSDASLWMRLPDLAAGLVCWLLLSREVLPRLGPAVAASKPAYWAAAMVLLTAWMPFNNGLRPEGIIALGSLVTYVLIERSMRYSRLTPAALAVVTAAFTLGVQPTGLIAVAALVAGGRPMLRILVRRHRLVGTLPLVSPMLAAGTVILTVVFADQTLSTVLEATRVRAKIGPSQAWYTENLRYYYLILPTVDGSLSRRFGFLITALCLFTAVFIMLRRKRIPSVARGPAWRLMGVIFGTMFFLMFTPTKWVHHFGLFAAVGAAMAALTTVLVSPSVLRWSRNRMAFLAALFFLLALCWATTNGWWYVSSYGVPFNSAMPKIDGITVSTIFFALFAIAAGYAAWLHFAPRGAGEGRLIRALTTAPVPIVAGFMAAVFVASMVAGIVRQYPTYSNGWSNVRAFVGGCGLADDVLVEPDTNAGFMKPLDGDSGSWGPLGPLGGVNPVGFTPNGVPEHTVAEAIVMKPNQPGTDYDWDAPTKLTSPGINGSTVPLPYGLDPARVPLAGTYTTGAQQQSTLVSAWYLLPKPDDGHPLVVVTAAGKIAGNSVLHGYTPGQTVVLEYAMPGPGALVPAGRMVPDDLYGEQPKAWRNLRFARAKMPADAVAVRVVAEDLSLTPEDWIAVTPPRVPDLRSLQEYVGSTQPVLLDWAVGLAFPCQQPMLHANGIAEIPKFRITPDYSAKKLDTDTWEDGTNGGLLGITDLLLRAHVMATYLSRDWARDWGSLRKFDTLVDAPPAQLELGTATRSGLWSPGKIRIGP